Skip to main content
Top
Published in: European Radiology 4/2021

01-04-2021 | Multiple Myeloma | Oncology

Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma

Authors: Lu Zhang, Qin Wang, Xia Wu, Ailin Zhao, Jun Feng, Haibo Zhang, Xinxin Cao, Shuo Li, Huacong Cai, Zhaoyong Sun, Minghui Duan, Tienan Zhu, Wei Zhang, Zhengyu Jin, Daobin Zhou, Huadan Xue, Jian Li

Published in: European Radiology | Issue 4/2021

Login to get access

Abstract

Objectives

To illuminate the prognostic value of ADC (apparent diffusion coefficient), an important quantitative parameter of diffusion-weighted MRI, for multiple myeloma (MM).

Methods

A prospective single-center study which enrolled 114 consecutive newly diagnosed MM patients with baseline whole-body diffusion-weighted MRI (WB DW-MRI) results was conducted. Baseline clinical and MRI parameters were analyzed with univariate and multivariate approaches to identify independent risk factors for progression-free survival (PFS) and overall survival (OS).

Results

Five different DW-MRI patterns were seen, and the mean ADC value of the representative background bone marrow was 0.4662 ± 0.1939 × 10−3 mm2/s. After a mean follow-up of 50.2 months (range, 15.7–75.8 months), twenty-four patients died and seven were lost to follow-up. The mean ADC value of the representative background bone marrow was showed to be an independent risk factor for both PFS (HR 4.664; 95% confidence interval (CI) 1.138–19.121; p = 0.032) and OS (HR 14.130; 95% CI 1.544–129.299; p = 0.019). Normal/salt-and-pepper pattern on DW-MRI was associated with PFS using univariate analysis (p = 0.035) but lost the significance with multivariate Cox regression.

Conclusions

Mean ADC value of the representative background bone marrow predicts both PFS and OS which suggests the role of baseline DW-MRI for risk stratification in newly diagnosed MM patients.

Key Points

• Whole-body diffusion-weighted MRI (WB DW-MRI) might be helpful to improve the current risk stratification systems for newly diagnosed multiple myeloma (MM).
• Morphological parameters as MRI pattern and focal lesion–associated parameters have been reported to be related to survival. However, important functional parameters such as apparent diffusion coefficient (ADC) values were not incorporated into the current risk stratification model.
• This study is one of the first endeavors to delineate the correlation of baseline ADC values and survival in MM patients. It is revealed that the mean ADC value of the representative background bone marrow (L3-S1 and iliac bone) was an independent risk factor for both PFS and OS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRef Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66:7–30CrossRef
2.
go back to reference D’Agostino M, Boccadoro M, Smith EL (2017) Novel immunotherapies for multiple myeloma. Curr Hematol Malig Rep 12:344–357CrossRef D’Agostino M, Boccadoro M, Smith EL (2017) Novel immunotherapies for multiple myeloma. Curr Hematol Malig Rep 12:344–357CrossRef
3.
go back to reference Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842–854CrossRef Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36:842–854CrossRef
4.
go back to reference Greipp PR, San Miguel J, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420CrossRef Greipp PR, San Miguel J, Durie BG et al (2005) International staging system for multiple myeloma. J Clin Oncol 23:3412–3420CrossRef
5.
go back to reference Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 33:2863–2869CrossRef Palumbo A, Avet-Loiseau H, Oliva S et al (2015) Revised international staging system for multiple myeloma: a report from International Myeloma Working Group. J Clin Oncol 33:2863–2869CrossRef
6.
go back to reference Pawlyn C, Morgan GJ (2017) Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer 17:543–556CrossRef Pawlyn C, Morgan GJ (2017) Evolutionary biology of high-risk multiple myeloma. Nat Rev Cancer 17:543–556CrossRef
7.
go back to reference Kyle RA, Gertz MA, Witzig TE et al (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21–33CrossRef Kyle RA, Gertz MA, Witzig TE et al (2003) Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21–33CrossRef
8.
go back to reference Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538–e548CrossRef Rajkumar SV, Dimopoulos MA, Palumbo A et al (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol 15:e538–e548CrossRef
9.
go back to reference D’Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M (2007) Guidelines for the use of imaging in the management of myeloma. Br J Haematol 137:49–63CrossRef D’Sa S, Abildgaard N, Tighe J, Shaw P, Hall-Craggs M (2007) Guidelines for the use of imaging in the management of myeloma. Br J Haematol 137:49–63CrossRef
10.
go back to reference Derlin T, Bannas P (2014) Imaging of multiple myeloma: current concepts. World J Orthop 5:272–282CrossRef Derlin T, Bannas P (2014) Imaging of multiple myeloma: current concepts. World J Orthop 5:272–282CrossRef
11.
go back to reference Lecouvet FE, Boyadzhiev D, Collette L et al (2020) MRI versus (18)F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance. Eur Radiol 30:1927–1937CrossRef Lecouvet FE, Boyadzhiev D, Collette L et al (2020) MRI versus (18)F-FDG-PET/CT for detecting bone marrow involvement in multiple myeloma: diagnostic performance and clinical relevance. Eur Radiol 30:1927–1937CrossRef
12.
go back to reference Larbi A, Omoumi P, Pasoglou V et al (2019) Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 29:4503–4513CrossRef Larbi A, Omoumi P, Pasoglou V et al (2019) Whole-body MRI to assess bone involvement in prostate cancer and multiple myeloma: comparison of the diagnostic accuracies of the T1, short tau inversion recovery (STIR), and high b-values diffusion-weighted imaging (DWI) sequences. Eur Radiol 29:4503–4513CrossRef
13.
go back to reference Lai AYT, Riddell A, Barwick T et al (2020) Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Eur Radiol 30:320–327CrossRef Lai AYT, Riddell A, Barwick T et al (2020) Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma. Eur Radiol 30:320–327CrossRef
14.
go back to reference Hillengass J, Fechtner K, Weber MA et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 28:1606–1610CrossRef Hillengass J, Fechtner K, Weber MA et al (2010) Prognostic significance of focal lesions in whole-body magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 28:1606–1610CrossRef
15.
go back to reference Mai EK, Hielscher T, Kloth JK et al (2016) Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology. Eur Radiol 26:3939–3948CrossRef Mai EK, Hielscher T, Kloth JK et al (2016) Association between magnetic resonance imaging patterns and baseline disease features in multiple myeloma: analyzing surrogates of tumour mass and biology. Eur Radiol 26:3939–3948CrossRef
16.
go back to reference Ailawadhi S, Abdelhalim AN, Derby L et al (2010) Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma. Cancer 116:84–92PubMed Ailawadhi S, Abdelhalim AN, Derby L et al (2010) Extent of disease burden determined with magnetic resonance imaging of the bone marrow is predictive of survival outcome in patients with multiple myeloma. Cancer 116:84–92PubMed
17.
go back to reference Mai EK, Hielscher T, Kloth JK et al (2015) A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma. Haematologica 100:818–825CrossRef Mai EK, Hielscher T, Kloth JK et al (2015) A magnetic resonance imaging-based prognostic scoring system to predict outcome in transplant-eligible patients with multiple myeloma. Haematologica 100:818–825CrossRef
18.
go back to reference Lee SY, Kim HJ, Shin YR, Park HJ, Lee YG, Oh SJ (2017) Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis. Eur Radiol 27:2333–2347CrossRef Lee SY, Kim HJ, Shin YR, Park HJ, Lee YG, Oh SJ (2017) Prognostic significance of focal lesions and diffuse infiltration on MRI for multiple myeloma: a meta-analysis. Eur Radiol 27:2333–2347CrossRef
19.
go back to reference Hillengass J, Bäuerle T, Bartl R et al (2011) Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol 153:721–728CrossRef Hillengass J, Bäuerle T, Bartl R et al (2011) Diffusion-weighted imaging for non-invasive and quantitative monitoring of bone marrow infiltration in patients with monoclonal plasma cell disease: a comparative study with histology. Br J Haematol 153:721–728CrossRef
20.
go back to reference Rasche L, Angtuaco EJ, Alpe TL et al (2017) The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood 132:59–66CrossRef Rasche L, Angtuaco EJ, Alpe TL et al (2017) The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma. Blood 132:59–66CrossRef
21.
go back to reference Lacognata C, Crimì F, Guolo A et al (2017) Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol 72:850–857CrossRef Lacognata C, Crimì F, Guolo A et al (2017) Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma. Clin Radiol 72:850–857CrossRef
22.
go back to reference Ye ZM, Dai SJ, Yan FQ et al (2018) DCE-MRI-derived volume transfer constant (Ktrans) and DWI apparent diffusion coefficient as predictive markers of short- and long-term efficacy of chemoradiotherapy in patients with esophageal cancer. Technol Cancer Res Treat 17:1533034618765254PubMedPubMedCentral Ye ZM, Dai SJ, Yan FQ et al (2018) DCE-MRI-derived volume transfer constant (Ktrans) and DWI apparent diffusion coefficient as predictive markers of short- and long-term efficacy of chemoradiotherapy in patients with esophageal cancer. Technol Cancer Res Treat 17:1533034618765254PubMedPubMedCentral
23.
go back to reference Xie H, Sun T, Chen M et al (2015) Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer: a systematic review and meta-analysis. Medicine (Baltimore) 94:e517CrossRef Xie H, Sun T, Chen M et al (2015) Effectiveness of the apparent diffusion coefficient for predicting the response to chemoradiation therapy in locally advanced rectal cancer: a systematic review and meta-analysis. Medicine (Baltimore) 94:e517CrossRef
24.
go back to reference Rajkumar SV (2012) Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol 87:78–88CrossRef Rajkumar SV (2012) Multiple myeloma: 2012 update on diagnosis, risk-stratification, and management. Am J Hematol 87:78–88CrossRef
25.
go back to reference Fonseca R, Blood E, Rue M et al (2003) Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101:4569–4575CrossRef Fonseca R, Blood E, Rue M et al (2003) Clinical and biologic implications of recurrent genomic aberrations in myeloma. Blood 101:4569–4575CrossRef
26.
go back to reference Hebraud B, Magrangeas F, Cleynen A et al (2015) Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience. Blood 125:2095–2100CrossRef Hebraud B, Magrangeas F, Cleynen A et al (2015) Role of additional chromosomal changes in the prognostic value of t(4;14) and del(17p) in multiple myeloma: the IFM experience. Blood 125:2095–2100CrossRef
27.
go back to reference Zhang H, Xue H, Alto S et al (2016) Integrated shimming improves lesion detection in whole-body diffusion-weighted examinations of patients with plasma disorder at 3 T. Invest Radiol 51:297–305CrossRef Zhang H, Xue H, Alto S et al (2016) Integrated shimming improves lesion detection in whole-body diffusion-weighted examinations of patients with plasma disorder at 3 T. Invest Radiol 51:297–305CrossRef
28.
go back to reference Messiou C, Giles S, Collins DJ et al (2012) Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol 85:e1198–e1203CrossRef Messiou C, Giles S, Collins DJ et al (2012) Assessing response of myeloma bone disease with diffusion-weighted MRI. Br J Radiol 85:e1198–e1203CrossRef
29.
go back to reference Giles SL, Messiou C, Collins DJ et al (2014) Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology 271:785–794CrossRef Giles SL, Messiou C, Collins DJ et al (2014) Whole-body diffusion-weighted MR imaging for assessment of treatment response in myeloma. Radiology 271:785–794CrossRef
30.
go back to reference Dimopoulos MA, Hillengass J, Usmani S et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33:657–664CrossRef Dimopoulos MA, Hillengass J, Usmani S et al (2015) Role of magnetic resonance imaging in the management of patients with multiple myeloma: a consensus statement. J Clin Oncol 33:657–664CrossRef
31.
go back to reference Durie BG, Harousseau JL, Miguel JS et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467–1473CrossRef Durie BG, Harousseau JL, Miguel JS et al (2006) International uniform response criteria for multiple myeloma. Leukemia 20:1467–1473CrossRef
32.
go back to reference Messiou C, Kaiser M (2015) Whole body diffusion weighted MRI--a new view of myeloma. Br J Haematol 171:29–37CrossRef Messiou C, Kaiser M (2015) Whole body diffusion weighted MRI--a new view of myeloma. Br J Haematol 171:29–37CrossRef
33.
go back to reference Koutoulidis V, Fontara S, Terpos E et al (2017) Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology 282:484–493CrossRef Koutoulidis V, Fontara S, Terpos E et al (2017) Quantitative diffusion-weighted imaging of the bone marrow: an adjunct tool for the diagnosis of a diffuse MR imaging pattern in patients with multiple myeloma. Radiology 282:484–493CrossRef
34.
go back to reference Andrulis M, Bauerle T, Goldschmidt H et al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970–974CrossRef Andrulis M, Bauerle T, Goldschmidt H et al (2014) Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology. Eur J Radiol 83:970–974CrossRef
35.
go back to reference Messiou C, Collins DJ, Morgan VA et al (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713–1718CrossRef Messiou C, Collins DJ, Morgan VA et al (2011) Optimising diffusion weighted MRI for imaging metastatic and myeloma bone disease and assessing reproducibility. Eur Radiol 21:1713–1718CrossRef
Metadata
Title
Baseline bone marrow ADC value of diffusion-weighted MRI: a potential independent predictor for progression and death in patients with newly diagnosed multiple myeloma
Authors
Lu Zhang
Qin Wang
Xia Wu
Ailin Zhao
Jun Feng
Haibo Zhang
Xinxin Cao
Shuo Li
Huacong Cai
Zhaoyong Sun
Minghui Duan
Tienan Zhu
Wei Zhang
Zhengyu Jin
Daobin Zhou
Huadan Xue
Jian Li
Publication date
01-04-2021
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 4/2021
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07295-6

Other articles of this Issue 4/2021

European Radiology 4/2021 Go to the issue